Header Logo

Connection

WOLFGANG WINKELMAYER to Time Factors

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Time Factors.
WOLFGANG WINKELMAYER
Connection Strength
1.725
Time Factors
  1. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.076
  2. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.072
  3. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol. 2017 Apr; 30(2):281-288.
    View in: PubMed
    Score: 0.065
  4. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol. 2016 Mar 29; 67(12):1459-1469.
    View in: PubMed
    Score: 0.064
  5. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
    View in: PubMed
    Score: 0.060
  6. Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
    View in: PubMed
    Score: 0.058
  7. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr; 14(4):943-951.
    View in: PubMed
    Score: 0.055
  8. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
    View in: PubMed
    Score: 0.055
  9. Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol. 2013 Apr 26; 14:97.
    View in: PubMed
    Score: 0.052
  10. Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
    View in: PubMed
    Score: 0.049
  11. Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol. 2012 Jun; 23(6):1078-85.
    View in: PubMed
    Score: 0.048
  12. Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005). J Nephrol. 2013 Mar-Apr; 26(2):281-8.
    View in: PubMed
    Score: 0.048
  13. Use of secondary prevention medications among adults with reduced kidney function. Clin J Am Soc Nephrol. 2012 Apr; 7(4):604-11.
    View in: PubMed
    Score: 0.048
  14. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2662-8.
    View in: PubMed
    Score: 0.047
  15. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011 Aug 08; 171(15):1371-8.
    View in: PubMed
    Score: 0.046
  16. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):57-65.
    View in: PubMed
    Score: 0.044
  17. Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure. Clin Pharmacol Ther. 2010 Oct; 88(4):548-54.
    View in: PubMed
    Score: 0.043
  18. Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury. Am J Med. 2008 Dec; 121(12):1092-8.
    View in: PubMed
    Score: 0.038
  19. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
    View in: PubMed
    Score: 0.037
  20. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
    View in: PubMed
    Score: 0.037
  21. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7.
    View in: PubMed
    Score: 0.035
  22. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006 Dec; 21(12):3559-66.
    View in: PubMed
    Score: 0.033
  23. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8.
    View in: PubMed
    Score: 0.032
  24. Effects of dialysate potassium concentration of 3.0?mmol/l with sodium zirconium cyclosilicate on?dialysis-free days versus dialysate potassium?concentration of 2.0 mmol/l alone on?rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int. 2025 Jan; 107(1):169-179.
    View in: PubMed
    Score: 0.029
  25. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant. 2004 Jul; 4(7):1148-54.
    View in: PubMed
    Score: 0.028
  26. Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol. 2004 Apr; 15(4):1052-60.
    View in: PubMed
    Score: 0.028
  27. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
    View in: PubMed
    Score: 0.027
  28. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003 Feb; 14(2):486-92.
    View in: PubMed
    Score: 0.026
  29. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
    View in: PubMed
    Score: 0.025
  30. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
    View in: PubMed
    Score: 0.025
  31. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001 Dec; 38(6):1178-84.
    View in: PubMed
    Score: 0.024
  32. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
    View in: PubMed
    Score: 0.023
  33. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
    View in: PubMed
    Score: 0.021
  34. The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration. J Am Soc Nephrol. 2019 05; 30(5):890-903.
    View in: PubMed
    Score: 0.020
  35. Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. J Am Soc Nephrol. 2019 02; 30(2):346-353.
    View in: PubMed
    Score: 0.019
  36. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.019
  37. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
    View in: PubMed
    Score: 0.019
  38. Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation. 2017 Apr; 101(4):851-857.
    View in: PubMed
    Score: 0.017
  39. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. J Cardiovasc Electrophysiol. 2017 01; 28(1):39-48.
    View in: PubMed
    Score: 0.017
  40. Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease. Heart. 2017 06; 103(11):818-826.
    View in: PubMed
    Score: 0.017
  41. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials. 2016 08 12; 17:401.
    View in: PubMed
    Score: 0.016
  42. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients. Am J Kidney Dis. 2016 Jan; 67(1):119-27.
    View in: PubMed
    Score: 0.015
  43. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.015
  44. Adiposity patterns and the risk for ESRD in postmenopausal women. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):241-50.
    View in: PubMed
    Score: 0.015
  45. Coronary artery bypass graft type and outcomes in maintenance dialysis. J Cardiovasc Surg (Torino). 2015 Jun; 56(3):463-71.
    View in: PubMed
    Score: 0.014
  46. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013; 8(11):e78930.
    View in: PubMed
    Score: 0.013
  47. Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. Clin J Am Soc Nephrol. 2014 Jan; 9(1):82-91.
    View in: PubMed
    Score: 0.013
  48. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
    View in: PubMed
    Score: 0.013
  49. Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2213-20.
    View in: PubMed
    Score: 0.013
  50. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
    View in: PubMed
    Score: 0.012
  51. Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children. Arch Dis Child. 2010 Aug; 95(8):634-8.
    View in: PubMed
    Score: 0.011
  52. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Transplantation. 2009 Dec 27; 88(12):1377-85.
    View in: PubMed
    Score: 0.010
  53. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiol Drug Saf. 2009 Oct; 18(10):932-40.
    View in: PubMed
    Score: 0.010
  54. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol. 2007 Aug; 22(8):1189-93.
    View in: PubMed
    Score: 0.009
  55. Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int. 2006 Aug; 19(8):629-35.
    View in: PubMed
    Score: 0.008
  56. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
    Score: 0.006
  57. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.